Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0003873 (
rheumatoid arthritis
)
53,068
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The first 100 consecutive patients who underwent insertion of the Taperloc (Biomet, Warsaw, IN) femoral stem were prospectively studied with a mean follow-up period of 3.8 years (range, 2-6 years). Two of the original 100 patients were lost, giving a 98% follow-up rate. The diagnoses included osteoarthritis (76 patients), avascular necrosis (19),
rheumatoid arthritis
(3), chrondrolysis (1), and post-traumatic arthritis (1). The mean age at surgery was 56 years (range, 25-79 years), mean weight was 78 kg (range, 45-127 kg), and the female to male ratio was 29:71. Charnley pain and function scores were 3.0 and 2.8 before surgery and 5.5 and 5.4 after surgery.
Thigh pain
was present in 2% of the patients at the final follow-up evaluation. There were no revisions. Radiographic signs of bone-ingrowth fixation (calcar atrophy, spot welds) were seen in 92 of 94 components (98%). No component had complete demarcation of the porous-coated zones. Fifty-two of 94 patients were able to be matched for age, sex, weight, diagnosis, and length of follow-up period with a series of patients who received a contemporary cemented total hip. In this matched subset, the Charnley pain and function scores were 5.6 and 5.5 for the cementless Taperloc stem and 5.7 and 5.5 for the cemented control group; this is not a significant difference. These data indicate a clinical performance equivalent to a matched group of contemporary cemented total hip arthroplasties.
...
PMID:Taperloc femoral component. A 2-6-year study of the first 100 consecutive cases. 780 5
Thirty-five porous-coated total hip arthroplasties were implanted in 25 patients with juvenile-onset or adult-onset
rheumatoid arthritis
and prospectively followed for a mean of 4.5 years (range, 3-6.5 years). Using the Harris hip rating, the mean hip score at the final follow-up evaluation was 91, and 86% of the hips had a good or excellent result. Thirty-one hips had no hip or
thigh pain
, while four had occasional slight pain. After surgery, 10 patients were employed and the remainder were ambulatory. There were no early or late deep infections. There was one reoperation for recurrent dislocation of the hip, but the components were not removed. Radiographic evaluation of the acetabular component showed that only one component had a complete radiolucent line in all three zones. Three femoral components had nonprogressive subsidence. At this intermediate-term follow-up period, porous-coated total hip arthroplasty is a promising technique that is likely to be successful in young patients with
rheumatoid arthritis
.
...
PMID:Porous-coated total hip arthroplasty in rheumatoid arthritis. 816 82
The outcome of total hip arthroplasty without cement was prospectively followed in patients who received a titanium taper wedge femoral component with a circumferential titanium plasma spray coating on the proximal surface (Integral femoral stem, Biomet, Warsaw, IN). One hundred ninety femoral components were implanted in 179 patients. Nine patients (9 hips) died prior to their 5-year examination, leaving 170 patients available for follow-up evaluation. Thirty-one of the 170 patients (33 hips) were lost at an intermediate follow-up period of 5 years. (mean, 5.8 years, range; 5-8 years), giving a follow-up rate of 82% for patients and hips. The preoperative diagnoses included osteoarthritis (91 hips), avascular necrosis (38), post-traumatic arthritis (10),
rheumatoid arthritis
(4), congenital dislocation of the hip (3), and fractures (2). The 78 men and 61 women had a mean age of 55 years (range, 18-81 years) and a mean weight of 81 kg (range, 50-136 kg). Pre-operative Harris pain and function scores for the hip were 19.9 (range, 0-40) and 55.6 (range, 12-84), respectively. At the most recent follow-up visit, the mean pain score increased to 41.2 (range, 10-44) and the mean function score increased to 93.5 (range, 6-100).
Thigh pain
was present in 4% of the hips at the most recent follow-up visit. Radiographically, 99% of the femoral components demonstrated spot welds in the porous-coated zone. Two hips had demarcation of the femoral component in the porous-coated zone consistent with fibrous fixation. None of the femoral stems had been revised and there were no signs of aseptic loosening. Additionally, there were no cases of pain that could be directly attributed to the stem and there was no evidence of distal femoral osteolysis. It is concluded that the integral femoral stem provides excellent clinical and radiographic results at intermediate follow-up periods.
...
PMID:Integral porous femoral stem. 5-to 8-Year follow-up study. 911 38
Sixty-two total hip arthroplasties in 49 patients with a diagnosis of
rheumatoid arthritis
were performed between November 1986 and December 1992. All components were titanium alloy with a circumferential plasma-spray porous coating. Four patients (4 hips) died before 5-year follow-up, and 6 patients (8 hips) were lost to follow-up, leaving 39 patients (50 hips) for review at a minimum 5-year follow-up after surgery (mean, 8 years; range, 5-12 years). There were 12 men and 27 women, with a mean age at time of surgery of 55 years (range, 25-77 years) and a mean weight of 69 kg (range, 42-109 kg). Compared with the preoperative Charnley scores, there was significant improvement in the postoperative scores: pain, from 2.7 to 5.7, and function, from 3.2 to 5.3.
Thigh pain
was present in 1 patient (1 hip) (2.0%). No femoral fractures occurred intraoperatively with the insertion of the prosthesis. Spot welds consistent with bone ingrowth were identified in all of the femoral components. No femoral components showed evidence of radiographic loosening or required revision for aseptic loosening or incapacitating
thigh pain
, but 7 acetabular revisions were performed. Uncemented femoral fixation with this component design in rheumatoid patients appears to be a promising treatment.
...
PMID:Cementless femoral fixation in the rheumatoid patient undergoing total hip arthroplasty: minimum 5-year results. 1140 2
The authors report their 15-year experience with primary total hip arthroplasty using collarless, tapered, porous-coated femoral stems (Trilock and Taperloc) in patients with osteoarthritis,
rheumatoid arthritis
, and in octogenarians. Excellent clinical results were achieved in all groups at latest followup. For the patients with Trilock stems, Taperloc stems, and patients who were octogenarians and patients with
rheumatoid arthritis
, Charnley pain scores were 5.6, 5.5, 5.7, and 5.7; Charnley function scores were 5.2, 5.1, 4.2, and 5.3; Harris hip scores were 92, 92, 82, and 93 points, respectively. There was a 2% rate of
thigh pain
with the Trilock, 4% with Taperloc, 4% in octogenarians, and 2% in patients with
rheumatoid arthritis
. In 96% of the patients in the Trilock group, in 100% of the patients in the Taperloc group, in 100% of the patients who were octogenarians, and in 100% of the patients with
rheumatoid arthritis
, femoral components showed radiographic evidence of bone ingrowth. There were six (12%) femoral component revisions in the Trilock group (all secondary to nonmodularity of the component at the time of acetabular revision), one femoral component revision in the Taperloc group and no femoral component revisions in the patients who were octogenarians or who had
rheumatoid arthritis
. Design features (collarless tapered wedge fit, circumferentially porous-coated) virtually ensure bone ingrowth and are thought to be responsible for the excellent clinical results and longevity.
...
PMID:Total hip arthroplasty using two different cementless tapered stems. 1176 40
We describe a 79-year-old woman with
rheumatoid arthritis
who suffered from subchondral insufficiency fracture of the femoral head (SIF) and contralateral femoral neck fracture. Radiographs obtained two months after the onset of
thigh pain
showed collapse of the right femoral head and contralateral femoral neck fracture. MRI revealed a subchondral serpiginous low-intensity band in the right femoral head on the T2-weighted image. This case report suggests that SIF should be considered in the differential diagnoses of rheumatic patients who suffer from
thigh pain
without antecedent trauma.
...
PMID:Co-occurrence of subchondral insufficiency fracture of the femoral head and contralateral femoral neck fracture in a rheumatic patient receiving steroid treatment. 1858 89
A 67-year-old woman with
rheumatoid arthritis
(RA; Steinblocker stage IV, class 4) who had RA onset at 34 years of age had anterior
thigh pain
, femoral neuropathy and lower abdominal pain. Physical examination showed multidirectional limit of motion, and radiographic examination showed destruction of the hip joint. MRI and arthrography indicated a cystic lesion that communicated with the hip joint. The rheumatoid synovial cyst was removed during total hip arthroplasty. The symptoms were relieved, and the mass was reduced in size.
...
PMID:Synovial cyst of the hip in a patient with rheumatoid arthritis. 2272 69
Atypical fractures of the diaphyseal femoral shaft have been reported in the literature at an increasing rate over the past few years. They have been observed mostly in patients who have been on prolonged courses of bisphosphonates, with no reported cases of atypical femoral fractures in those treated with other anti-resorptive medications. A 59 year old woman sustained an atypical fracture of her right femur in March 2013. She had a past medical history of
rheumatoid arthritis
and osteoporosis. She had been on alendronate but it was discontinued after five years in 1999. She received denosumab by subcutaneous injection in December 2012. At follow up, she complained of pain in her left femur and a radiograph revealed atypical appearances. She was admitted in June 2013 for prophylactic nailing of the left femur. To our knowledge, this is the first reported case of bilateral atypical femoral changes in a patient prescribed denosumab. Given that denosumab has been on the market for a short time period, we expect that the number of these cases will increase with time. We emphasise previous guidance that patients who present with new onset hip or
thigh pain
should be screened for atypical femoral fractures.
...
PMID:Bilateral atypical femoral fractures in a patient prescribed denosumab - a case report. 2438 66